Ahmed M. Elshazly

The BET inhibitor/degrader ARV-825 prolongs the growth arrest response to Fulvestrant + Palbociclib and suppresses proliferative recovery in ER-positive breast cancer

Ryan Finnegan, Ahmed M. Elshazly, Nipa Patel et al. · Frontiers in Oncology · 2023 · 23 citations · Full text

Medicine, Oncology, Pharmacology +17

Topoisomerase I poisons-induced autophagy: Cytoprotective, Cytotoxic or Non-protective

Ahmed M. Elshazly, Polina Wright, Jingwen Xu et al. · Autophagy Reports · 2022 · 22 citations · Full text

Medicine, Oncology, Pharmacology +17

BRD4 Inhibition as a Strategy to Prolong the Response to Standard of Care in Estrogen Receptor-Positive Breast Cancer

Ahmed M. Elshazly, Melanie M. Sinanian, Victoria Neely et al. · Cancers · 2023 · 11 citations · Full text

Medicine, Oncology, Pharmacology +16

Autophagy and senescence facilitate the development of antiestrogen resistance in ER positive breast cancer

Michael K. McGrath, Ali Abolhassani, Luke Guy et al. · Frontiers in Endocrinology · 2024 · 11 citations · Full text

Medicine, Endocrinology, Oncology +17